Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
KROS
Keros Therapeutics, Inc.
NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close
$11.40
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
PHARMACEUTICAL PREPARATIONS
Market cap
$226.03M
Country
USA
RECENT INSIDER TRADES
2026-08-20
· Tanini Annita
(Corp. Controller & VP, Finance)
· SELL
2026-08-20
· Lerner Lorena Raquel
(Chief Scientific Officer)
· SELL
2026-08-20
· Newton Charles W.
(Director)
· SELL
2026-08-20
· Cho Esther
(Chief Legal Officer)
· SELL
2026-08-19
· BIENAIME JEAN JACQUES
(Director)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
150
Shares held
23,141,911
Value
$351.15M
Percent of shares outstanding
116.72%
As of quarter end
2026-06-30
RECENT NEWS
Keros Therapeutics to receive $20M milestone from Takeda
Keros to receive $20 million milestone payment from Takeda
Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD
Keros Therapeutics, Inc. · 8-K (8.01,9.01)
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Keros Therapeutics, Inc. (KROS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit